Did Tylenol tweet in 2017 about pregnancy? Response issued about resurfaced post
Share and Follow


Tylenol’s parent company said the 2017 tweet didn’t address its full guidance on the safe use of Tylenol which has not changed.

WASHINGTON — Following President Donald Trump promoting unproven links between Tylenol use during pregnancy and autism, a 2017 social media post by the pain reliever is drawing renewed attention. 

The March 2017 post from Tylenol’s official Twitter, now X, account was a response to someone else’s tweet and said that it didn’t recommend using any of its products while pregnant. Some in the president’s base have pointed to the resurfaced post as evidence supporting Trump. 

However, Kenvue Inc., the parent company of Tylenol, stressed that the “eight-year-old consumer response is incomplete and did not address our full guidance on the safe use of Tylenol which has not changed.” 

Kenvue said Tylenol, known by the generic name acetaminophen, is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy.

“We recommend pregnant women do not take any over-the-counter medication, including acetaminophen, without talking to their doctor first,” Kenvue added in a statement. 

During a White House news conference on Monday, Trump instructed pregnant women around a dozen times to not take acetaminophen.

Some studies have raised the possibility that taking the over-the-counter painkiller in pregnancy might be associated with a risk of autism — but many others haven’t found a connection.

In recent days, Tylenol’s 2017 tweet has been flooded by responses and comments. The company hasn’t posted on its X account in more than four years. 

Kenvue has been refuting Trump’s claims. The company’s website about Tylenol notes that “credible, independent scientific data” shows no proven link between acetaminophen and autism.

It also links to statements from several medical associations discrediting any connection.

“Tylenol is one of the most studied medications in history–and is safe when used as directed by expecting mothers, infants and children,” Tylenol’s website states. “The facts remain unchanged: over a decade of rigorous research, endorsed by leading medical professionals, confirm there is no credible evidence linking acetaminophen to autism.”

The Associated Press contributed to this report. 

Share and Follow
You May Also Like
Remains exhumed in Oregon’s oldest unidentified person case

Oregon’s Longest Unsolved Mystery: Exhuming Remains for Identification

() Investigators in Oregon are hoping they’re one step closer to solving…
Anti-ICE messages found on shooter's rounds in deadly attack on Dallas ICE facility, FBI says

Anti-ICE messages found on shooter’s rounds in deadly attack on Dallas ICE facility, FBI says

Gunman ID’ed after Dallas ICE facility attack Fox News correspondent Brooke Taylor…
Mets retake lead in NL wild-card race with win over Cubs

Mets Secure Top Spot in NL Wild-Card Race After Victory Against Cubs

CHICAGO — After spending 54 hours removed from the driver’s seat, the…
Father and son reel in 650-pound fish in Hawaii

Father and Son Catch Massive 650-Pound Fish in Hawaii

HONOLULU (KHON2) – A Hawaiian father and son duo made a big…
GOP hopes to make potential shutdown as painful for Dems as possible

GOP Aims to Intensify Shutdown Impact on Democrats

President Trump and GOP lawmakers are itching to make a potential government…
Man convicted of Trump killing plot tries to stab himself after verdict

Man Found Guilty in Trump Assassination Plot Attempts Self-Harm Post-Verdict

() Ryan Routh, the man who tried to kill then-candidate Donald Trump…
Robot umpires approved for MLB in 2026 as part of challenge system

MLB to Introduce Robot Umpires in 2026 as Part of New Challenge System

Robot umpires are coming to the big leagues in 2026 after Major…
France says UN recognition of Palestinian state is a blow to Hamas not a gift

France says UN recognition of Palestinian state is a blow to Hamas not a gift

NEWYou can now listen to Fox News articles! Pascal Confavereux, spokesperson for…